Go Back
RA Capital Management
RA Capital Management, a venture fund based in Boston, Massachusetts, was founded in 2001. Specializing in the healthcare, biotech, and AI/ML sectors, the fund invests across various stages from Pre-Seed to Series D. Partnered with Peter Kolchinsky, they have made 288 investments in companies like Somatus, Exo, and Element Biosciences, with 140 successful exits. RA Capital Management focuses on life sciences and drug development, with a diverse portfolio including startups such as GentiBio, Ceribell, and ViaCyte. For more information, visit their website at www.racap.com.
About
About
About
Bio
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Location
Boston, Massachusetts
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Peter Kolchinsky
Bio
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Location
Boston, Massachusetts
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Peter Kolchinsky
Fund
Fund
Fund
Fund Focus
Healthcare, Medical Device, Health & Wellness, BioTech, Life Science, Pharmaceuticals, Artificial Intelligence & Machine Learning (AI/ML)
Number of investments
288
Number of exits
140
Fund Type
Venture Fund
Portfolio Companies
Somatus, Exo, Element Biosciences, Mineralys Therapeutics, Sionna Therapeutics, GentiBio, Boundless Bio, Artiva Biotherapeutics, Frontier Medicines, Ceribell, Be Biopharma, Scribe Therapeutics, Tasso, Antios Therapeutics, Acrivon Therapeutics, Cedilla Therapeutics, Curie Therapeutics, Locanabio, Plexium, Obsidian Therapeutics, Electra Therapeutics, ViaCyte, Synthekine, Asher Bio, Jnana Therapeutics, DTx Pharma
RA Capital Management
RA Capital Management, a venture fund based in Boston, Massachusetts, was founded in 2001. Specializing in the healthcare, biotech, and AI/ML sectors, the fund invests across various stages from Pre-Seed to Series D. Partnered with Peter Kolchinsky, they have made 288 investments in companies like Somatus, Exo, and Element Biosciences, with 140 successful exits. RA Capital Management focuses on life sciences and drug development, with a diverse portfolio including startups such as GentiBio, Ceribell, and ViaCyte. For more information, visit their website at www.racap.com.
About
Bio
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Location
Boston, Massachusetts
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Peter Kolchinsky
Fund
Fund Focus
Healthcare, Medical Device, Health & Wellness, BioTech, Life Science, Pharmaceuticals, Artificial Intelligence & Machine Learning (AI/ML)
Number of investments
288
Number of exits
140
Fund Type
Venture Fund
Portfolio Companies
Somatus, Exo, Element Biosciences, Mineralys Therapeutics, Sionna Therapeutics, GentiBio, Boundless Bio, Artiva Biotherapeutics, Frontier Medicines, Ceribell, Be Biopharma, Scribe Therapeutics, Tasso, Antios Therapeutics, Acrivon Therapeutics, Cedilla Therapeutics, Curie Therapeutics, Locanabio, Plexium, Obsidian Therapeutics, Electra Therapeutics, ViaCyte, Synthekine, Asher Bio, Jnana Therapeutics, DTx Pharma